ArticleOncoimmunology
The Interleukin (IL)-1R1 pathway is a critical negative regulator of PyMT-mediated mammary tumorigenesis and pulmonary metastasis.
Maryse Dagenais et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
cites it